株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

掻痒治療薬の世界市場:2020年~2024年

Global Pruritus Therapeutic Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 538564
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.30円で換算しております。
掻痒治療薬の世界市場:2020年~2024年 Global Pruritus Therapeutic Market 2020-2024
出版日: 2020年04月09日 ページ情報: 英文 120 Pages
概要

世界の掻痒治療薬市場は、2020年から2024年の予測期間中に6%のCAGRで成長し、36億3,000万米ドルの規模に達する見込みです。 市場は、掻痒症および薬物誘発性掻痒の有病率の増加が主な成長要因となっています。特に、掻痒症の有病率の増加によって、市場成長が更に促進される見通しです。

当レポートでは、世界の掻痒治療薬市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

タイプ別市場セグメンテーション

  • 市場セグメンテーション
  • タイプ別比較:市場規模・予測(2019年~2024年)
  • 腎掻痒症
  • 胆汁うっ滞性掻痒症
  • 血液学的掻痒症
  • 内分泌掻痒症
  • 腫瘍性掻痒症
  • タイプ別市場機会

顧客情勢

  • 概要

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模・予測(2019年~2024年)
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域
  • 主要国
  • 地域別の市場機会

成長要因、課題、動向

  • 市場成長要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • 情勢の革新

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Allergan Plc
  • アステラス製薬
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.

付録

目次
Product Code: IRTNTR43185

Technavio has been monitoring the pruritus therapeutic market and it is poised to grow by $ 3.63 bn during 2020-2024 progressing at a CAGR of 6% during the forecast period. Our reports on pruritus therapeutic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of pruritus and drug-induced pruritus. In addition, increasing prevalence of pruritus is anticipated to boost the growth of the market as well.

The pruritus therapeutic market analysis includes type segments and geographic landscapes

Technavio's ‘ pruritus therapeutic market ’ is segmented as below:

By Type

  • Renal pruritus
  • Cholestatic pruritus
  • Hematologic pruritus
  • Endocrine pruritus
  • Oncological pruritus

By Geography

  • North America
  • Europe
  • APAC
  • ROW

This study identifies the strong pipeline of expected launches as one of the prime reasons driving the pruritus therapeutic market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our pruritus therapeutic market covers the following areas:

  • Pruritus therapeutic market sizing
  • Pruritus therapeutic market forecast
  • Pruritus therapeutic market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pruritus therapeutic market vendors that include Abbott Laboratories, Allergan Plc, Astellas Pharma Inc., Cipla Inc., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd.. Also, the pruritus therapeutic market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Other 1

  • Market segments
  • Comparison by Other1
  • Renal pruritus - Market size and forecast 2019-2024
  • Cholestatic pruritus - Market size and forecast 2019-2024
  • Hematologic pruritus - Market size and forecast 2019-2024
  • Endocrine pruritus - Market size and forecast 2019-2024
  • Oncological pruritus - Market size and forecast 2019-2024
  • Market opportunity by Other1

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Allergan Plc
  • Astellas Pharma Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Parent market
  • 9.Market characteristics
  • 10.Offerings of vendors included in the market definition
  • 11.Market segments
  • 12.Global - Market size and forecast 2019 - 2024 ($ million)
  • 13.Global market: Year-over-year growth 2019 - 2024 (%)
  • 14.Five forces analysis 2019 & 2024
  • 15.Bargaining power of buyers
  • 16.Bargaining power of suppliers
  • 17.Threat of new entrants
  • 18.Threat of substitutes
  • 19.Threat of rivalry
  • 20.Market condition - Five forces 2019
  • 21.Other1 - Market share 2019-2024 (%)
  • 22.Comparison by Other1
  • 23.Renal pruritus - Market size and forecast 2019-2024 ($ million)
  • 24.Renal pruritus - Year-over-year growth 2019-2024 (%)
  • 25.Cholestatic pruritus - Market size and forecast 2019-2024 ($ million)
  • 26.Cholestatic pruritus - Year-over-year growth 2019-2024 (%)
  • 27.Hematologic pruritus - Market size and forecast 2019-2024 ($ million)
  • 28.Hematologic pruritus - Year-over-year growth 2019-2024 (%)
  • 29.Endocrine pruritus - Market size and forecast 2019-2024 ($ million)
  • 30.Endocrine pruritus - Year-over-year growth 2019-2024 (%)
  • 31.Oncological pruritus - Market size and forecast 2019-2024 ($ million)
  • 32.Oncological pruritus - Year-over-year growth 2019-2024 (%)
  • 33. Market opportunity by Other1
  • 34.Customer landscape
  • 35.Market share by geography 2019-2024 (%)
  • 36.Geographic comparison
  • 37.North America - Market size and forecast 2019-2024 ($ million)
  • 38.North America - Year-over-year growth 2019-2024 (%)
  • 39.Europe - Market size and forecast 2019-2024 ($ million)
  • 40.Europe - Year-over-year growth 2019-2024 (%)
  • 41.APAC - Market size and forecast 2019-2024 ($ million)
  • 42.APAC - Year-over-year growth 2019-2024 (%)
  • 43.ROW - Market size and forecast 2019-2024 ($ million)
  • 44.ROW - Year-over-year growth 2019-2024 (%)
  • 45.Key leading countries
  • 46.Market opportunity by geography ($ million)
  • 47.Impact of drivers and challenges
  • 48.Vendor landscape
  • 49.Landscape disruption
  • 50.Industry risks
  • 51.Vendors covered
  • 52.Market positioning of vendors
  • 53.Abbott Laboratories - Overview
  • 54.Abbott Laboratories - Business segments
  • 55.Abbott Laboratories - Key offerings
  • 56.Abbott Laboratories - Key customers
  • 57.Abbott Laboratories - Segment focus
  • 58.Allergan Plc - Overview
  • 59.Allergan Plc - Business segments
  • 60.Allergan Plc - Key offerings
  • 61.Allergan Plc - Key customers
  • 62.Allergan Plc - Segment focus
  • 63.Astellas Pharma Inc. - Overview
  • 64.Astellas Pharma Inc. - Business segments
  • 65.Astellas Pharma Inc. - Key offerings
  • 66.Astellas Pharma Inc. - Key customers
  • 67.Astellas Pharma Inc. - Segment focus
  • 68.Cipla Inc. - Overview
  • 69.Cipla Inc. - Business segments
  • 70.Cipla Inc. - Key offerings
  • 71.Cipla Inc. - Key customers
  • 72.Cipla Inc. - Segment focus
  • 73.GlaxoSmithKline Plc - Overview
  • 74.GlaxoSmithKline Plc - Business segments
  • 75.GlaxoSmithKline Plc - Key offerings
  • 76.GlaxoSmithKline Plc - Key customers
  • 77.GlaxoSmithKline Plc - Segment focus
  • 78.Merck & Co. Inc. - Overview
  • 79.Merck & Co. Inc. - Business segments
  • 80.Merck & Co. Inc. - Key offerings
  • 81.Merck & Co. Inc. - Key customers
  • 82.Merck & Co. Inc. - Segment focus
  • 83.Novartis AG - Overview
  • 84.Novartis AG - Business segments
  • 85.Novartis AG - Key offerings
  • 86.Novartis AG - Key customers
  • 87.Novartis AG - Segment focus
  • 88.Pfizer Inc. - Overview
  • 89.Pfizer Inc. - Business segments
  • 90.Pfizer Inc. - Key offerings
  • 91.Pfizer Inc. - Key customers
  • 92.Pfizer Inc. - Segment focus
  • 93.Sanofi - Overview
  • 94.Sanofi - Business segments
  • 95.Sanofi - Key offerings
  • 96.Sanofi - Key customers
  • 97.Sanofi - Segment focus
  • 98.Sun Pharmaceutical Industries Ltd. - Overview
  • 99.Sun Pharmaceutical Industries Ltd. - Business segments
  • 100.Sun Pharmaceutical Industries Ltd. - Key offerings
  • 101.Sun Pharmaceutical Industries Ltd. - Key customers
  • 102.Sun Pharmaceutical Industries Ltd. - Segment focus
  • 103.Currency conversion rates for US$
  • 104.Research Methodology
  • 105.Research Methodology
  • 106.Validation techniques employed for market sizing
  • 107.Information sources
  • 108.List of abbreviations